Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report

MeSH terms

• Angiogenesis Inhibitors / adverse effects
• Angiogenesis Inhibitors / therapeutic use*
• Benzenesulfonates / adverse effects
• Benzenesulfonates / therapeutic use*
• Carcinoma, Hepatocellular / drug therapy*
• Carcinoma, Hepatocellular / enzymology
• Carcinoma, Hepatocellular / pathology
• Carcinoma, Hepatocellular / surgery
• Chemotherapy, Adjuvant
• Diffusion Magnetic Resonance Imaging
• Hepatectomy
• Humans
• Liver Neoplasms / drug therapy*
• Liver Neoplasms / enzymology
• Liver Neoplasms / pathology
• Liver Neoplasms / surgery
• Male
• Middle Aged
• Molecular Targeted Therapy
• Niacinamide / analogs & derivatives
• Phenylurea Compounds
• Protein Kinase Inhibitors / adverse effects
• Protein Kinase Inhibitors / therapeutic use*
• Pyridines / adverse effects
• Pyridines / therapeutic use*
• Sorafenib
• Time Factors
• Treatment Outcome
• alpha-Fetoproteins / metabolism
• raf Kinases / antagonists & inhibitors
• raf Kinases / metabolism